Company Monitoring Page for Regeneron

latest headlines for company on cafepharma

Pfizer, Amgen, Regeneron Pharmaceuticals: How the PCSK9 Market is Evolving
Bidness, ETC
Thu, 07/7/16 - 03:41 pm
Tags:
Pfizer, Amgen, Regeneron, PCSK9 inhibitors, Repatha, Praluent
Regeneron and Sanofi Announce Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia in Japan
Yahoo
Tue, 07/5/16 - 10:10 am
Tags:
Regeneron, Sanofi, Praluent, Japan, PCSK9 inhibitors
3 Potential Stock-Moving Drug Events In The Second Half Of 2016
Investors.com
Fri, 07/1/16 - 10:07 am
Tags:
Eli Lilly, solanezumab, Alzheimer's disease, Gilead Sciences, hepatitis C, Sovaldi, Harvoni, Epclusa, Sanofi, Regeneron, Praluent
Pfizer's bococizumab may hit the PCSK9 market just in time
Fierce Pharma
Thu, 06/30/16 - 09:32 am
Tags:
Pfizer, bococizumab, PCSK9 inhibitors, Amgen, Sanofi, Regeneron
Drug Companies Need to Tell a Better Story, Regeneron CEO Says
Yahoo/Bloomberg
Wed, 06/29/16 - 12:51 pm
Tags:
Regeneron, Pharma CEOs, pharma industry
Regeneron Pharmaceuticals Inc: Eylea and Praluent Sales Growth Under Risk
Bidness, ETC
Sat, 06/18/16 - 02:21 pm
Tags:
Regeneron, Eyelea, Praluent
Amgen, Inc. can Force Praluent Off Market but Regeneron Pharmaceuticals Inc May Still Be OK
Bidness, ETC
Thu, 06/16/16 - 03:22 pm
Tags:
Amgen, Sanofi, Regeneron, Praluent, Repatha, patents, PCSK9 inhibitors
Biotech Stocks: Much Ado About Nothing at ASCO?
Barron's
Mon, 06/6/16 - 11:30 pm
Tags:
ASCO 2016, biotech, Celgene, Amgen, Regeneron, Gilead Sciences
Sanofi and Regeneron report positive skin disease trial
Yahoo/Reuters
Mon, 06/6/16 - 10:46 am
Tags:
Sanofi, Regeneron, dupilumab, monoclonal antibodies, clinical trials
Next-generation eczema drugs on pace for 2017 launch
BioPharma Dive
Wed, 06/1/16 - 09:41 pm
Tags:
eczema, drug launches, Anacor, Regeneron, Sanofi
What Pfizer's Anacor Deal May Mean For It And For Regeneron
Seeking Alpha
Mon, 05/16/16 - 09:39 pm
Tags:
Pfizer, Anacor, Regeneron, M&A
Regeneron CEO says drug price critique by independent group unscientific
Yahoo/Reuters
Fri, 05/13/16 - 09:54 am
Tags:
Regeneron, drug pricing, Pharma CEOs, Leonard Schleifer
Regeneron first-quarter profit more than doubles
Yahoo/Reuters
Thu, 05/5/16 - 09:59 am
Tags:
Regeneron, earnings
Regeneron Nips At Amgen And Pfizer's Heels In Pain Drug Race
Seeking Alpha
Tue, 05/3/16 - 09:46 pm
Tags:
Regeneron, Amgen, Pfizer, painkillers, fasinumab, clinical trials
Regeneron pain drug clears late-stage trial
Yahoo/Reuters
Mon, 05/2/16 - 10:05 am
Tags:
Regeneron, clinical trials, fasinumab, osteoarthritis pain
What’s Regeneron Expecting for Revenue in 1Q16?
Yahoo/Market Realist
Thu, 04/28/16 - 09:41 am
Tags:
Regeneron, earnings
Allergan Could Eye Regeneron and Biogen for Acquisition
Bidness, ETC
Wed, 04/20/16 - 12:02 pm
Tags:
Allergan, Biogen, Regeneron, M&A
CRISPR biotech Intellia strikes licensing deal with Regeneron, readies IPO
BioPharma Dive
Mon, 04/11/16 - 11:22 pm
Tags:
CRISPR, Intellia Therapeutics, Regeneron, IPOs
2 Biotech Companies That Could Profit if Their Skin Treatments Are Successful
TheStreet.com
Tue, 04/5/16 - 10:06 pm
Tags:
Regeneron, dupilumab, Anacor, Crisaborole Topical Ointment, psoriasis, eczema
Regeneron Pharmaceuticals Inc Jumps on Positive Clinical Data
Motley Fool
Sat, 04/2/16 - 02:00 pm
Tags:
Regeneron, clinical trials, dupilumab, eczema, atopic dermatitis

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.